Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Daiichi Sankyo, Ranbaxy look to Venezuela
August 2012
SHARING OPTIONS:

TOKYO—Daiichi Sankyo Co. Ltd. and Ranbaxy Laboratories Ltd. have announced the launch of a hybrid business model in Venezuela. Daiichi Sankyo Venezuela SA, a subsidiary of Daiichi Sankyo, will begin marketing Ranbaxy products in Venezuela as part of the business model. Ranbaxy has been marketing its products in Venezuela through a local distributor, but Daiichi Sankyo Venezuela will assume that role in its stead and has already begun promotion of Ranbaxy products. Daiichi Sankyo initiated its presence in Venezuela—which boasts the third-largest pharmaceutical market in Latin America—with pharmaceuticals such as Benicar, its hypertension medicine. The company now plans to expand Ranbaxy's product portfolio to promote the hybrid business model.               

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.